ATRECA

Atreca is a biopharmaceutical that develops a technology to identify the set of antibodies produced during an immune response, without prior knowledge of an antigen. Its product candidate, ATRC-101, is a monoclonal antibody in preclinical development with a novel mechanism of action and target-derived from an antibody identified using its discovery platform.

#People #Financial #Event #Website #More

ATRECA

Social Links:

Industry:

Biotechnology Health Care Product Research Therapeutics

Founded:

2010-01-01

Address:

San Carlos, California, United States

Country:

United States

Website Url:

http://www.atreca.com

Total Employee:

101+

Status:

Active

Contact:

Email Addresses:

[email protected]

Total Funding:

347.86 M USD

Technology used in webpage:

Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt WordPress Wordpress Plugins Mobile Non Scaleable Content

Current Employees Featured

wayne-volkmuth_image

Wayne Volkmuth
Wayne Volkmuth SVP Informatics and IT, Co-founder @ Atreca
SVP Informatics and IT, Co-founder

jonathan-woo_image

Jonathan Woo
Jonathan Woo Senior Vice President, Finance & Strategy, Co-Founder @ Atreca
Senior Vice President, Finance & Strategy, Co-Founder

john-a-orwin_image

John A Orwin
John A Orwin President and CEO @ Atreca
President and CEO
2018-04-01

daniel-emerling_image

Daniel Emerling
Daniel Emerling Senior Vice President, Research . Co-Founder @ Atreca
Senior Vice President, Research . Co-Founder
2011-01-01

christopher-murriel_image

Christopher Murriel
Christopher Murriel Director, In Vivo Pharmacology @ Atreca
Director, In Vivo Pharmacology
2020-03-01

stephen-gould_image

Stephen Gould
Stephen Gould Chief Scientific Officer @ Atreca
Chief Scientific Officer
2022-06-01

herb-c-cross_image

Herb C. Cross
Herb C. Cross Chief Financial Officer @ Atreca
Chief Financial Officer
2019-04-01

tito-a-serafini_image

Tito A Serafini
Tito A Serafini Chief Strategy Officer, Director, & Founder @ Atreca
Chief Strategy Officer, Director, & Founder
2018-04-01

Founder

daniel-emerling_image

Daniel Emerling

guy-cavet_image

Guy Cavet

jonathan-woo_image

Jonathan Woo

paulette-dillon_image

Paulette Dillon

tito-a-serafini_image

Tito A Serafini

wayne-volkmuth_image

Wayne Volkmuth

yann-chong-tan_image

Yann Chong Tan

Stock Details

Company's stock symbol is NASDAQ:BCEL

Investors List

wellington-management_image

Wellington Management

Wellington Management investment in Series C - Atreca

samsara-biocapital_image

Samsara BioCapital

Samsara BioCapital investment in Series C - Atreca

tavistock-group_image

Tavistock Group

Tavistock Group investment in Series C - Atreca

redmile-group_image

Redmile Group

Redmile Group investment in Series C - Atreca

cormorant-asset-management_image

Cormorant Asset Management

Cormorant Asset Management investment in Series C - Atreca

boxer-capital_image

Boxer Capital

Boxer Capital investment in Series C - Atreca

aisling-capital_image

Aisling Capital

Aisling Capital investment in Series C - Atreca

ecor1-capital_image

EcoR1 Capital

EcoR1 Capital investment in Series C - Atreca

tekla-capital-management_image

Tekla Capital Management

Tekla Capital Management investment in Series C - Atreca

cormorant-asset-management_image

Cormorant Asset Management

Cormorant Asset Management investment in Series B - Atreca

Key Employee Changes

Date	New article
2022-06-16	Atreca Appoints Stephen Gould, Ph.D. as Chief Scientific Officer

Official Site Inspections

http://www.atreca.com Semrush global rank: 3.83 M Semrush visits lastest month: 3.46 K

Host Informations
Whois Informations

Loading ...

More informations about "Atreca" on Search Engine